GLP-1 weight-loss drugs: What are they and how do they work? GLP-1 weight-loss drugs offer promising results but come with potential risks and unknown long-term effects, emphasizing the need for ...

Airlines stand to save a potential $580 million as travelers slim down thanks to the effects of weight-loss drugs, a new study found. Sheila Kahyaoglu, an equity analyst at Jefferies and an author of ...

As the popularity of weight-loss drugs continues to boom, it has opened the door for scammers eager to dupe people into buying fake versions of the medications. The Better Business Bureau has issued a ...

Longtime talk show host Oprah Winfrey is opening up about her recent weight-loss success after sticking to a GLP-1 (glucagon-like peptide-1). Winfrey, 71, began taking a GLP-1 medication in 2023, but ...

A Wegovy pill is now available in pharmacies nationwide. The weight loss medication is an alternative to GLP-1 injections. Below, a weight loss expert shares what you need to know. Wegovy—a medication ...

At this point, millions of people in the U.S. have tried at least one of a variety of glucagonlike peptide 1 (GLP-1) receptor agonist drugs such as Zepbound or Wegovy. For some, these medications have ...

Share on Pinterest The Food and Drug Administration (FDA) recently approved a tablet version of the GLP-1 drug Wegovy for weight loss. Image courtesy of Novo Nordisk Novo Nordisk officials said a new ...

Editor’s Note: This post is focused on helping you understand profit and loss statements. This financial statement is used by most small business owners to help assess business profits and losses ...

Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including Wegovy and Zepbound are expected to be easier to access and afford. And new ...

Despite the Rams’ comeback efforts on Monday night, erasing a 21-point deficit in order to claw back on the road against the Falcons, they were unable to get a win. Having already clinched the ...

NEW YORK, Dec 24 (Reuters) - Packaged food makers and fast-food restaurants may be forced to overhaul more of their products next year as newly approved, appetite-suppressing GLP-1 pills become ...

The next transformative phase of weight-loss medication is upon us, with the US Food and Drug Administration (FDA) approving Novo Nordisk's highly anticipated oral GLP-1 drug – with a starting dose ...